Search results
ImmunoGen (IMGN) Q1 Earnings Beat, Elahere Uptake Encouraging
Zacks via Yahoo Finance· 1 year agoImmunoGen (IMGN) reports impressive Q1 earnings results on strong adoption of sole-marketed drug...
News Flash: Analysts Just Made An Incredible Upgrade To Their ImmunoGen, Inc. (NASDAQ:IMGN)...
Simply Wall St. via Yahoo Finance· 1 year agoCelebrations may be in order for ImmunoGen, Inc. (NASDAQ:IMGN) shareholders, with the analysts...
Biotech Leader ImmunoGen Eyes Early Buy Point Amid Path To Profitability
Investor's Business Daily· 7 months agoBiotech leader ImmunoGen, Monday's pick for IBD 50 Growth Stocks To Watch, is approaching an early...
AbbVie joins ADC dealmaking with $10B ImmunoGen buyout
BioPharma Dive via Yahoo Finance· 7 months agoAbbVie is expanding its investment in targeted cancer medicines, announcing Thursday a $10.1 billion...
ImmunoGen, Day One Surge On Cancer Drug Updates, But Arcus Dips
Investor's Business Daily· 1 year agoImmunoGen and Day One Biopharmaceuticals unveiled promising cancer treatment updates over the...
AbbVie seeks lift from 'guided missile' cancer drug with $10 billion ImmunoGen deal
Reuters via Yahoo Finance· 7 months ago(Reuters) -AbbVie will buy ImmunoGen for $10.1 billion in cash, it said on Thursday, the latest...
Why Abbvie Stock Popped Today
Motley Fool· 7 months agoThe big asset buy in the healthcare industry provided a healthy pop to the two companies involved on Thursday. The stock price of the buyer, sector...
Zacks.com featured highlights include Confluent, Pinterest, ICON and ImmunoGen
Zacks via Yahoo Finance· 7 months agoFor Immediate Release Chicago, IL – November 8, 2023 – Stocks in this week’s article are Confluent...
Good News for Patients Is Lifting These 2 Biopharma Stocks
Motley Fool· 1 year agoOverall, the stock market is facing a serious case of the jitters on Wednesday morning, as investors...
Biotech Stock Roundup: HZNP Surges on AMGN Offer, TRDA Gains on VRTX Deal & More
Zacks via Yahoo Finance· 2 years agoThe biotech sector was in the spotlight this week courtesy of acquisition news and strategic...
